市場調査レポート
商品コード
1387409
インシリコ創薬市場レポート:2030年までの動向、予測、競合分析In-Silico Drug Discovery Market Report: Trends, Forecast and Competitive Analysis to 2030 |
● お客様のご希望に応じて、既存データの加工や未掲載情報(例:国別セグメント)の追加などの対応が可能です。 詳細はお問い合わせください。
インシリコ創薬市場レポート:2030年までの動向、予測、競合分析 |
出版日: 2023年11月01日
発行: Lucintel
ページ情報: 英文 150 Pages
納期: 3営業日
|
インシリコ創薬の動向と予測
世界のインシリコ創薬市場は、2024年から2030年までのCAGRが10.2%で、2030年までに推定54億5,000万米ドルに達すると予想されます。この市場の主な促進要因は、投薬ミスの減少に向けた注目の高まり、創薬におけるクラウドベースのアプリケーションの採用の増加、計算生物学における継続的な進歩です。世界のインシリコ創薬市場の将来は、CRO、製薬業界、学術・研究機関市場にビジネスチャンスがあり、有望視されています。
インシリコ創薬市場の洞察
Lucintel社の予測によると、創薬プロセスにおけるバーチャルスクリーニングやターゲット探索への採用が増加していることから、サービスとしてのソフトウェアが予測期間中に最も高い成長を遂げる見込みです。
インシリコ創薬は製薬会社の新薬開発期間短縮とコスト削減に貢献するため、同市場では製薬業界が最大セグメントであり続けるでしょう。
北米は、バイオ製薬企業による研究開発費の増加、大手製薬企業の存在感、さまざまな慢性疾患や感染症に苦しむ患者が多いことから、予測期間中も最大地域であり続けるでしょう。
In-Silico Drug Discovery Trends and Forecast
The future of the global in-silico drug discovery market looks promising with opportunities in the contract research organizations, pharmaceutical industry, and academic & research institutes markets. The global in-silico drug discovery market is expected to reach an estimated $5.45 billion by 2030 with a CAGR of 10.2% from 2024 to 2030. The major drivers for this market are rising focus towards reduction of medication errors, increasing adoption of cloud-based applications in drug discovery, and on-going advancements in computational biology.
A more than 150-page report is developed to help in your business decisions.
In-Silico Drug Discovery by Segment
The study includes a forecast for the global in-silico drug discovery by type, target therapeutic area, workflow, end use, and region.
In-Silico Drug Discovery Market by Type [Shipment Analysis by Value from 2018 to 2030]:
In-Silico Drug Discovery Market by Target Therapeutic Area [Shipment Analysis by Value from 2018 to 2030]:
In-Silico Drug Discovery Market by Workflow [Shipment Analysis by Value from 2018 to 2030]:
In-Silico Drug Discovery Market by End Use [Shipment Analysis by Value from 2018 to 2030]:
In-Silico Drug Discovery Market by Region [Shipment Analysis by Value from 2018 to 2030]:
List of In-Silico Drug Discovery Companies
Companies in the market compete on the basis of product quality offered. Major players in this market focus on expanding their manufacturing facilities, R&D investments, infrastructural development, and leverage integration opportunities across the value chain. With these strategies in-silico drug discovery companies cater increasing demand, ensure competitive effectiveness, develop innovative products & technologies, reduce production costs, and expand their customer base. Some of the in-silico drug discovery companies profiled in this report include-
In-Silico Drug Discovery Market Insights
Lucintel forecasts that software as a service is expected to witness the highest growth over the forecast period due to its increasing adoption for virtual screening and target fising in the drug discovery procedure.
Within this market, pharmaceutical industry will remain the largest segment due as in-silico drug discovery helps the pharmaceutical companies to reduce the time and cost of developing new drugs.
North America will remain the largest region over the forecast period due to increasing R&D expenditure by biopharma company, strong presence of marlet players, and large patient population suffering from various chronic and infectious diseases in the region.
Features of the Global In-Silico Drug Discovery Market
Market Size Estimates: In-silico drug discovery market size estimation in terms of value ($B).
Trend and Forecast Analysis: Market trends (2018 to 2023) and forecast (2024 to 2030) by various segments and regions.
Segmentation Analysis: In-silico drug discovery market size by various segments, such as by type, target therapeutic area, workflow, end use, and region in terms of value ($B).
Regional Analysis: In-silico drug discovery market breakdown by North America, Europe, Asia Pacific, and Rest of the World.
Growth Opportunities: Analysis of growth opportunities in different types, target therapeutic areas, workflow, end uses, and regions for the in-silico drug discovery market.
Strategic Analysis: This includes M&A, new product development, and competitive landscape of the in-silico drug discovery market.
Analysis of competitive intensity of the industry based on Porter's Five Forces model.
FAQ
Q1. What is the in-silico drug discovery market size?
Answer: The global in-silico drug discovery market is expected to reach an estimated $5.45 billion by 2030.
Q2. What is the growth forecast for in-silico drug discovery market?
Answer: The global in-silico drug discovery market is expected to grow with a CAGR of 10.2% from 2024 to 2030.
Q3. What are the major drivers influencing the growth of the in-silico drug discovery market?
Answer: The major drivers for this market are rising focus towards reduction of medication errors, increasing adoption of cloud-based applications in drug discovery, and on-going advancements in computational biology.
Q4. What are the major segments for in-silico drug discovery market?
Answer: The future of the in-silico drug discovery market looks promising with opportunities in the contract research organizations, pharmaceutical industry, and academic & research institutes markets.
Q5. Who are the key in-silico drug discovery market companies?
Answer: Some of the key in-silico drug discovery companies are as follows:
Q6. Which in-silico drug discovery market segment will be the largest in future?
Answer: Lucintel forecasts that software as a service is expected to witness the highest growth over the forecast period due to its increasing adoption for virtual screening and target fising in the drug discovery procedure.
Q7. In in-silico drug discovery market, which region is expected to be the largest in next 5 years?
Answer: North America will remain the largest region over the forecast period due to increasing R&D expenditure by biopharma company, strong presence of marlet players, and large patient population suffering from various chronic and infectious diseases in the region.
Q.8 Do we receive customization in this report?
Answer: Yes, Lucintel provides 10% customization without any additional cost.